• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.56% Nasdaq Down 0.98%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    33.26 Down 1.38(3.98%) 3:59PM EDT - NYSE Real Time Price
    Add to Portfolio
    Prev Close:34.64
    Open:34.41
    Bid:33.30 x 400
    Ask:33.37 x 400
    1y Target Est:42.50
    Beta:0.864764
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:33.22 - 35.46
    52wk Range:19.31 - 36.20
    Volume:202,986
    Avg Vol (3m):271,623
    Market Cap:1.29B
    P/E (ttm):34.47
    EPS (ttm):0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EBS

    Comparison

    Symbol% ChgMkt Cap
    EBSDown 3.98%1.29B
    AMGNDown 2.45%115.31B

    Key Statistics

    Forward P/E (1 yr):18.04
    P/S (ttm):2.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.45
    Quarterly EPS Est (Sep-15) :0.55
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.36

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Emergent BioSolutions Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes specialized products for use in biodefense and commercial markets in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback